Search
Now showing items 1-6 of 6
Formulation of 5–Fluorouracil for transdermal delivery
(North-West University, 2010)
Non–melanoma skin cancer (NMSC) is the most common human malignancy and it is estimated that over 1.3 million cases are diagnosed each year in the United States (Neville et al., 2007:462). There are three main types of ...
The effect of emulsifiers and penetration enhancers in emulsions on dermal and transdermal delivery
(North-West University, 2008)
Emulsions are widely used as the delivery vehicles of active ingredients. The aim of this project was the investigation of the effect of the emulsifier system on dermal and transdermal delivery. Four different actives with ...
Pheroid technology for the transdermal delivery of lidocaine and prilocaine
(North-West University, 2008)
Local anaesthetics have been implemented extensively in the case of a variety of painful
superficial procedures, venipuncture, skin graft harvesting, anal or genital pruritus, poison ivy rashes, postherpetic neuralgia ...
Formulation, in vitro release and transdermal diffusion of anti-inflammatory gel preparations containing diclofenac salts
(North-West University, 2010)
Most individuals are influenced by pain at some stage in their lives. It can either be of acute or chronic nature. An acute pain condition initiates and is treated within a time span of 12 weeks. Chronic pain can, however, ...
Formulation, in vitro release and transdermal diffusion of isoniazide and rifampicin for dermal tuberculosis
(North-West University, 2009)
Extra pulmonary tuberculosis makes up 10% of all tuberculosis cases and cutaneous tuberculosis (CTB) only a fraction of this 10%. CTB is caused by mainly Mycobacterium tuberculosis and can lead to scarring and deformities. ...
Transdermal penetration of acyclovir in the presence and absence of terpenes
(North-West University, 2003)
Acyclovir is an antiviral drug used in the treatment and prevention of herpes simplex and varicella-zoster viral infections. The major problem in the transdermal delivery of acyclovir is the permeation in sufficient amounts ...